Inflammatix is a Biotech company based in Palo Alto, California. It has raised $200M in total funding.
Inflammatix funding overview
Inflammatix is a Biotech company based in Palo Alto, California. Inflammatix has raised $200M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Investors on record include OSF Ventures, D1 Capital Partners, Think.Health, Northpond Ventures, Khosla Ventures, Stanford-StartX Fund and 1 others. 7 distinct backers are named across the disclosed rounds.
Inflammatix has raised $200M in total disclosed funding across the rounds on record.
Who has invested in Inflammatix?
OSF Ventures, D1 Capital Partners, Think.Health, Northpond Ventures, Khosla Ventures, Stanford-StartX Fund are named among the investors backing Inflammatix.
What was the latest Inflammatix funding round?
No round stage has been disclosed for Inflammatix.
Where is Inflammatix based?
Inflammatix is based in Palo Alto, California.
What sector does Inflammatix operate in?
Inflammatix is tracked under Biotech from Palo Alto, California, with $200M in disclosed funding.
Every Inflammatix figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare Biotech companies in Palo Alto at a similar stage.
